Featured Research

from universities, journals, and other organizations

Epigenetics To Shape Stem Cell Future

Date:
February 23, 2007
Source:
European Science Foundation
Summary:
Everyone hopes that one day stem cell-based regenerative medicine will help repair diseased tissue. Before then, it may be necessary to decipher the epigenetic signals that give stem cells their unique ability to self-renew and transform them into different cell types.

Everyone hopes that one day stem cell-based regenerative medicine will help repair diseased tissue. Before then, it may be necessary to decipher the epigenetic signals that give stem cells their unique ability to self-renew and transform them into different cell types.

Related Articles


The hype over epigenetic research is because it opens up the possibility of reprograming cells. By manipulating epigenetic marks, cells can be transformed into other cell types without changing their DNA. It is simply a question of adding or removing the chemical tags involved.

Stem cells rely heavily on epigenetic signals. As a stem cell develops, chemical tags on the DNA or its surrounding histone proteins switch genes on or off, controlling a cell’s fate.

European labs are breaking ground in both the epigenetic and stem cell arenas. To build on this expertise and stimulate the exchange on novel technologies, the European Science Foundation organised the EuroSTELLS workshop ‘Exploring chromatin in stem cells.’ The event held on 23- 24 January, 2007 attracted 106 researchers from 15 countries to Montpellier, France.

“Epigenetics and stem cell biology are such clear strengths in the European research community,” remarked Bradley Bernstein, a guest speaker from Massachusetts General Hospital, Boston. “We’ve found ourselves working very hard in the US to catch up.”

Epigenetic research has benefited tremendously from genome technology, and work in the field is advancing at break-neck speed. “If you think that the first enzymes controlling histone methylation were found in 2001, the acceleration is tremendous,” says Robert Feil, a EuroSTELLS researcher based at the CNRS Institute of Molecular Genetics in Montpellier. “We are making good use of past investments in genome sequencing. In the next five years the technology will be ten times faster than it has been so far.”

Conference goers reported that new high-throughput approaches and refined analytical techniques promise to fill in some big gaps in understanding how epigenetic tags define a stem cell and how they can be manipulated. With this knowledge on board, researchers will be boosting the odds that one day stem cell therapies will reach the clinic.

EuroSTELLS is the European Collaborative Research (EUROCORES) programme on “Development of a Stem Cell Tool Box” developed by the European Science Foundation.


Story Source:

The above story is based on materials provided by European Science Foundation. Note: Materials may be edited for content and length.


Cite This Page:

European Science Foundation. "Epigenetics To Shape Stem Cell Future." ScienceDaily. ScienceDaily, 23 February 2007. <www.sciencedaily.com/releases/2007/02/070220003740.htm>.
European Science Foundation. (2007, February 23). Epigenetics To Shape Stem Cell Future. ScienceDaily. Retrieved November 27, 2014 from www.sciencedaily.com/releases/2007/02/070220003740.htm
European Science Foundation. "Epigenetics To Shape Stem Cell Future." ScienceDaily. www.sciencedaily.com/releases/2007/02/070220003740.htm (accessed November 27, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, November 27, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins